Questions discussed in this category
Additional risk factors could be family history of VTE or thrombophilia, such as antithrombin deficiency.
Thrombophilia testing, including JAK2 is negative. When would you stop anticoagulation?
Thrombosis of the greater saphenous vein extending from SFJ to mid-calf, unchanged on follow-up Doppler imaging after 3 months of full dose rivaroxaba...
Cardiolipin was mildly positive and persistent after 12 weeks (29->28 MPL). No other significant provoking factors. The patient started on LMWH.
W...
The patient takes frequent flights for their job, with no prior history of VTE, and has already been taking measures for prevention including frequent...
Would you anticoagulate for a fixed or indefinite duration? Would you recommend changing her contraception method?
Would you label this as intermediate or high risk and treat with prophylactic or full dose AC? What duration would you treat for?
No prior hx of DVT/SVT. Negative LE doppler. Would you consider anticoagulating and at what dose, or favor close observation?
Assume patient requires anticoagulation in the setting of acute thrombosis, with no need for IVC filter, but is approaching the end of her third trime...
Are the INRs reliable? In what scenarios would you not recommend POC INR use for warfarin monitoring?
Are these typically covered by insurance? Are t...
Would you still plan for lifelong anticoagulation in this scenario?
E.g. young male, morbid obesity, with BMI >50
While follow up ultrasound is not usually recommended in provoked DVT, it often is done either for other reasons or by other physicians. Would this in...
Is patch or gel HRT with ASA prophylaxis a reasonable option after counseling? Or do you add a prophylactic DOAC?
Is lifelong LMWH the anticoagulant of choice? Would DOACs be an option?
Would you consider low dose indefinite anticoagulation in any scenario? Any difference in approach between hematological malignancy and solid tum...
No prior thrombosis; no family history of thrombosis. As per endocrine, the only useful therapy for the osteoporosis is estrogen.
E.g. pulmonary embolism, portal vein thrombosis, cerebral venous sinus thrombosis
Would the answer differ if the index event was arterial vs venous?
Previous provoking factors resolved (CVC, malignancy, etc)
If work-up is sent and the patient is found to have a persistently positive antiphospholipid antibody, particularly lupus anticoagulant, would you con...
Currently on nonwarfarin therapeutic anticoagulation
The patient has no personal history of VTE, but has positive family history of VTE.
Any prophylactic anticoagulation options?
How would manage...
Is it time limited since it may have been triggered by the pregnancy or is it indefinite since it is APLS associated?
I.e., what constitutes well-controlled cancer, IBD, nephrotic syndrome, etc. What other diseases do you put in this category (obesity, autoimmune dise...
i.e. long car rides or plane rides
FVL heterozygotes are often treated similarly to the general population. Aside from avoiding other VTE risk factors, are there situations where prophy...
Would you offer indefinite anticoagulation if the event is unprovoked and the patient has low bleeding risk?
If so, what agent(s) do you prefer?
What is your duration of anticoagulation?
Provoked or unprovoked VTE: Do you use D-Dimer (or even repeat imaging to reassess residual clot) in any capacity to guide anticoagulation duration? E...
Is there data that it actually helps?
While there are many factors involving:- type (DVT vs PE, unprovoked vs provoked) and severity of venous thromboembolism (VTE) size- duration of antic...
Do you follow the 2019 EULAR Guidelines that SLE patients with asymptomatic, positive aPL should be on low-dose ASA?
While thrombophilia testing is not routinely recommended prior to starting OCPs, how about after the development of a VTE?
Ref: EINSTEIN-CHOICE and AMPLIFY-EXT
Would you approach this differently in patients with inherited thrombophilias?
20574213802075722139219792177521189211592146317211208952070513319195291596217846187181856293881815316703157551713116617165631481312302148801481014842884313903137081121813511126921214181331066612000112769961110441097892861061410560875210082984492639019
Papers discussed in this category
Blood, 2013-12-05
Blood Adv,
Blood,
Thrombosis, 2013
Thrombosis journal, 2023 Oct 26
N Engl J Med, 2021 Apr 14
J Natl Cancer Inst, 2011 Jul 09
Br J Clin Pharmacol, 2020 Jun 02
Semin Hematol,
Blood advances, 2018-11-27
Blood advances, 2018-11-27
Autoimmun Rev, 2017 Sep 09
Blood Adv, 2017 Jun 22
Lancet,
Post reproductive health, 2022 Dec 27
Haematologica, 2019 Jan 03
The New England journal of medicine, 2013-02-21
J Thromb Haemost, 2021 Jul 14
The New England journal of medicine, 2017 Mar 18
Circulation. Cardiovascular interventions, 2015-10
Research and practice in thrombosis and haemostasis, 2018 Oct 19
Thrombosis and haemostasis, 2019 Oct 28
Journal of thrombosis and haemostasis : JTH, 2021 Apr 01
Circulation, 2011-12-20
American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013-01
American journal of nephrology, 2013
Journal of the American Heart Association, 2021 Jun 26
Autoimmunity reviews, 2017 Feb 13
Thrombosis research, 2023 Feb 10
Lupus, 2017 Mar 29
Journal of thrombosis and haemostasis : JTH, 2019 Sep 13
The Journal of clinical endocrinology and metabolism, 2024 Jan 18
Stroke, 2023 Sep 07
Stroke, 2024 Jan 29
Blood advances, 2024 Jul 09
Blood advances, 2024 Aug 13
The Journal of clinical endocrinology and metabolism, 2018 May 01
The Journal of urology, 2022 Jan 20
Haematologica, 2009 Oct 14
American journal of hematology, 2023 Jul 20
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2008-01
Journal of general internal medicine, 2007-01
Blood advances, 2018-11-27
Blood advances, 2023 Nov 28
Annals of the rheumatic diseases, 2019-10
Arthritis & rheumatology (Hoboken, N.J.), 2023 Aug 28
Circulation, 2018 Apr 3
The Lancet. Haematology, 2017 Feb 16
Journal of evaluation in clinical practice, 2018 Dec 21
Archives of medical science : AMS, 2019 Mar 04
Blood, 2013 Jul 02
The New England journal of medicine, 2010 Sep 23
Blood, 2014 Nov 14